Dr Stanley Yu

Consultant Clinical Oncologist

Specialist in Clinical Oncology

MD (Res) (London, UK)

PG Dip (Oncology) (London, UK)

MBBS (UCL)

MRCP (UK)

FRCR (UK)

FHKCR

FHKAM (Radiology)

Research & Publications

■ PRESENTATIONS

The prognostic relevance of MRI Tumor Regression Grade versus histopathological complete response in rectal cancer
(First Author)
S.Yu, D Tait, G Brown
Oral Presentation in ESMO Conference: 17th World Congress on Gastrointestinal Cancer 4 July, 2015: Barcelona, Spain

The effect of adjuvant chemotherapy following neoadjuvant chemoradiation on persistently positive EMVI stage II and III rectal cancer
M Chand, S Yu, S Rasheed, RI Swift, P Tekkis, S Rao, G Brown
Poster Presentation in European Society of Coloproctology on 25 September 2014

Magnetic Resonance Tumour regression grade and clinical criteria as predictors for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy.
Bhoday J, Smith F, Siddiqui M, Yu S, Balyasnikova S, Swift I, Tait D, Heald RJ, Brown G
2nd International Controversies in Rectal Cancer Conference on 9 September 2014

Use of MRI-defined Tumour Distance from the Anal Verge to Predict Tumour Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
(First Author)
Poster Presentation in Gastrointestinal Cancers Symposium, ASCO Jan 2012: San Francisco USA

A prospective multicentre study to evaluate the diagnostic ability of multimodality imaging (FDG PET/CT, MRI and DW-MRI) in detecting early rectal tumour regrowth in cases of deferral of rectal surgery following continued response to preoperative chemoradiotherapy.
S. Chua, S. Yu, B. Drake, U. Patel, D. Tait, G. Cook, R. Heald, I. Chau, G. Brown
Oral Presentation at the European Journal of Nuclear Medicine and Molecular Imaging Meeting 2011

Deferral of rectal surgery following a continued response to preoperative chemoradiotherapy (Watch and Wait) study: A phase II multicenter study in the United Kingdom.
(First Author)
Poster Presentation in Gastrointestinal Cancers Symposium, ASCO Jan 2011: San Francisco, USA

Evaluation in Acute Toxicity in CT Conformal versus Simulator Planned Preoperative Chemoradiotherapy in Rectal Carcinoma
(First Author)
Poster Presentation in ESMO Conference: 12th World Congress on Gastrointestinal Cancer 30 June to 3 July, 2010: Barcelona, Spain

■ PUBLICATIONS

PAN-EX: A pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer
Ann Oncol (2016) doi: 10.1093/annonc/mdw215 First published online: May 23, 2016
F. Sclafani, G. Brown, D. Cunningham, A. Wotherspoon, D. Tait, C. Peckitt, J. Evans, S. Yu, L. Sena Teixeira Mendes, J. Tabernero, B. Glimelius, A. Cervantes, J. Thomas, R. Begum, J. Oates and I. Chau

The prognostic relevance of MRI Tumor Regression Grade versus histopathological complete response in rectal cancer
Ann Oncol (2015) 26 (suppl 4): iv114 doi:10.1093/annonc/mdv235.16
(First Author)
S.Yu, D Tait, G Brown

MR imaging for rectal cancer: the role in staging the primary and response to neoadjuvant therapy.
Expert Rev Gastroenterol Hepatol. 2014 Jun 23:1-17. [Epub ahead of print]
Battersby NJ, Moran B, Yu S, Tekkis P, Brown G.

The prognostic relevance of MRI Tumor Regression Grade versus histopathological complete response in Rectal Cancer
Submitted to Journal of Clinical Oncology
(First Author)
Yu SKT, Chau I, Cunningham D, Tait D, Gimelius B, Cervanles A, Tabernero J, Heald R, Dewdney A, Wong R, Chua YJ, Wotherspoon A, Peckitt C, Gina Brown

MRI defined Mucinous Rectal Carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative Chemoradiotherapy
European Journal of Cancer, Volume 50, Issue 5, Pages 920-927, March 2014
(First Author)
Stanley Yu, Manish Chand, Diana M Tait, Gina Brown

Chemoradiotherapy response in recurrent rectal cancer
Cancer Medicine, Volume 3, Issue 1, pages 111–117, February 2014
(First Author)
Stanley Yu, Aneel Bhangu, Diana M. Tait, Paris Tekkis, Andrew Wotherspoon & Gina Brown

Mucinous carcinoma of the rectum: a distinct clinicopathological entity.
Tech Coloproctol. 2014 Apr;18(4):335-44. Epub 2013 Dec 11.
Chand M, Yu S, Swift RI, Brown G.

MRI Predictive Factors for Tumor Response in Rectal Cancer Following Neoadjuvant Chemoradiation Therapy – Implications for Induction Chemotherapy?
Int J Radiation Oncol Biol Phys, Vol. 87, No. 3, pp. 505-511, 2013
(First Author)
Stanley K.T. Yu, Diana Tait, Ian Chau, and Gina Brown

Primary Staging and Response Assessment post Chemoradiotherapy in Rectal Cancer.
Colorectal Cancer Feb 2012, Vol 1, Number 1, P57-70
(First Author)
Stanley KT Yu, Uday B Patel, Diana Tait, Gina Brown

Use of MRI-defined Tumour Distance from the Anal Verge to Predict Tumour Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
J Clin Oncol 30, 2012 (suppl 4; abstr 573)
(First Author)
Yu SKT, Brown G, Tait DM

A prospective multicentre study to evaluate the diagnostic ability of multimodality imaging (FDG PET/CT, MRI and DW-MRI) in detecting early rectal tumour regrowth in cases of deferral of rectal surgery following continued response to preoperative chemoradiotherapy.
European Journal of Nuclear Medicine and Molecular Imaging. Volume 38, Supplement 2, Oct 2011, s157
S. Chua, S. Yu, B. Drake, U. Patel, D. Tait, G. Cook, R. Heald, I. Chau, G. Brown.

Deferral of rectal surgery following a continued response to preoperative chemoradiotherapy (Watch and Wait) study: A phase II multicenter study in the United Kingdom.
J Clin Oncol 29: 2011 (suppl 4; abstr 489)
(First Author)
S. K. Yu, G. Brown, R. J. Heald, S. Chua, G. Cook, Y. Barbachano, I. Chau, A. Wotherspoon, D. M. Tait

Evaluation in Acute Toxicity in CT Conformal versus Simulator Planned Preoperative Chemoradiotherapy in Rectal Carcinoma
Annals of Oncology July 2010; 21(6) Pvi 61
(First Author)
Yu S, Farmakidis D, Raouf S

Patients Receiving Standard-dose Temozolomide Therapy are at Risk of Pneumocystis carinii Pneumonia
Clinical Oncology, Volume 19, Issue 8, October 2007, Pages 631-632
(First Author)
S.K.T. Yu and A.J. Chalmers